DENTSPLY SIRONA Profit Margin 2010-2023 | XRAY

Current and historical gross margin, operating margin and net profit margin for DENTSPLY SIRONA (XRAY) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. DENTSPLY SIRONA net profit margin as of December 31, 2023 is -3.33%.
DENTSPLY SIRONA Annual Profit Margins
DENTSPLY SIRONA Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $6.490B $3.965B
DENTSPLY SIRONA Inc. is a global leader in the design, development, manufacture and marketing of dental consumables, dental laboratory products, dental specialty products and consumable medical device products. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. The business has been organized into two reporting segments: Dental & Healthcare Consumables and Technologies.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.728B 18.40
Becton Dickinson (BDX) United States $67.941B 19.73
West Pharmaceutical Services (WST) United States $27.818B 47.03
Cardinal Health (CAH) United States $25.564B 15.37
Align Technology (ALGN) United States $23.702B 47.80
Cooper (COO) United States $18.588B 28.13
Labcorp (LH) United States $17.307B 14.78
Henry Schein (HSIC) United States $9.123B 15.78
Merit Medical Systems (MMSI) United States $4.217B 24.13
STAAR Surgical (STAA) United States $2.433B 76.60
CONMED (CNMD) United States $2.296B 21.62
Patterson (PDCO) United States $2.281B 10.93
Atrion (ATRI) United States $0.703B 36.21
Lifevantage (LFVN) United States $0.080B 12.90
Pro-Dex (PDEX) United States $0.063B 24.05
Biolase (BIOL) United States $0.005B 0.00